A strong enterprise profile and a planned merger with Portland-based Oregon Health & Science University continues to help shore up the overall rating, S&P Global stressed.
“The rating further reflects our view of Legacy’s pressured operations, with significant operating losses in fiscal 2023 driving a notable decline in DCOH,” according to the note.
Such days’ cash on hand numbers are expected to improve over the next year to approximately 200, S&P said. That number was 172 as of Sept. 30 with an $11.9 million operating loss reported for the quarter ending Sept. 30.
Legacy Health and OHSU have signed a letter of intent to merge operations, with a definitive agreement expected later in fiscal 2024, S&P said.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
